Nu Skin Q4 prelim revenue at high end of guidance; closed Mavely deal for $250M

NU SKIN ENTERPRISES, INC.

2024-FY EPS reported -$2.95 revenue$1,732,084,000

Q4 2024 preliminary revenue at high end of company's guidance range.
Recently closed strategic transaction of Mavely for $250 million.
Full Q4 and FY2024 results to be announced on Feb. 13, 2025.
CEO Ryan Napierski and CFO James Thomas to present at ICR Conference on Jan. 14.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.